Connect to share and comment

China and India face huge cancer burden

China and India are facing a cancer crisis, with smoking, belated diagnosis and unequal access to treatment all causing large-scale problems, experts said on Friday. In a major report, published in The Lancet Oncology, more than 40 specialists warn that Asia's big two emerging giants are facing huge economic and human costs from the disease. In China, cancer now accounts for one in every five deaths, ranking second only to cardiovascular disease as the most common cause of mortality, according to the study.

For teen girls, fruits and veggies linked to lower risk of breast condition

By Kathryn Doyle NEW YORK (Reuters Health) - Teenage girls who eat more colorful fruits and vegetables are less likely to develop benign breast disease as young adults, according to a new study. Benign breast disease, or a group of lumps that can develop during adolescence or young adulthood, is not in itself dangerous. But benign breast disease does increase the risk of breast cancer later in life, the authors of the new study write.

Promise seen with Pfizer breast cancer drug

An experimental cancer drug made by Pfizer has shown signs of promise at slowing the spread of advanced breast cancer, researchers said. The drug, called palbociclib, when administered with another anti-cancer drug already on the market, letrozole, stopped cancer progression for a median of 20 months. That was double the amount of time seen in a control group of patients who did not receive palbociclib.

Could half of all breast cancers be prevented?

By Anne Harding NEW YORK (Reuters Health) - If girls and women of all ages adopted healthier lifestyle behaviors and the highest-risk women took preventive drugs like tamoxifen, the authors of a new report say fully half of breast cancers in the U.S. might be avoided.

Radiation improves odds for some women after mastectomy

By Andrew M. Seaman NEW YORK (Reuters Health) - Women who have their breasts removed because of cancer may benefit from receiving radiation if they still have traces of cancer in their lymph nodes, suggests a new analysis. Radiation reduced the risk of death and of cancer returning among women who had cancer cells detected in the cluster of nodes under the arms after a mastectomy. The nodes are part of the lymphatic system, a conduit for immune and other cells.

Supreme court declines to hear 'I (heart sign) boobies' case

By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Monday declined to hear a school district's appeal over an attempt by officials to ban breast cancer awareness bracelets bearing the message "I (heart sign) boobies," handing victory to two students who challenged the decision on free speech grounds. The court's decision not to take up the case means that an August 2013 ruling by the Philadelphia-based 3rd U.S. Circuit Court of Appeals in favor of students Brianna Hawk and Kayla Martinez is left intact.

Women with BRCA should have ovaries removed sooner to prevent cancers: study

TORONTO - Women who carry a BRCA genetic mutation have a significantly reduced chance of developing ovarian cancer and dying prematurely if they opt to have their ovaries and fallopian tubes preventively removed earlier than later, a study suggests.

Aveo, Astellas end pact to develop cancer drug tivozanib

(Reuters) - Aveo Oncology and Astellas Pharma Inc said they would end an agreement to develop Aveo's lead experimental drug that has seen a string of failures in multiple cancer indications. Aveo, which cut 62 percent of its workforce last year to focus on developing the drug, tivozanib, as a treatment for breast and colon cancers, said in December that the drug was not likely to succeed in a mid-stage trial testing its use in colon cancer. The companies said on Friday they would discontinue the study.

Nine breast cancer patients in Newfoundland had inaccurate breast cancer tests

ST. JOHN'S, N.L. - Nine patients in Newfoundland and Labrador had incorrect breast cancer test results, resulting in overly aggressive treatments for them, the province's largest health authority said Thursday. Eastern Health said it discovered a problem on Dec. 9, when it found a test result from its lab did not match with one during a quality assurance test. The health board said it stopped its testing at the lab and sent new tests to an external lab for follow-up.

Opting for double mastectomy may up survival rate in BRCA breast cancer: study

TORONTO - Women with BRCA-related breast cancer who have a double mastectomy are half as likely to die of the disease within 20 years compared to those who opt for removal of only the cancerous breast, a Canadian-led study has found. The findings, published in this week's issue of the British Medical Journal, suggest a double mastectomy may be an effective first-line treatment for women with early-stage breast cancer who carry a BRCA1 or BRCA2 genetic mutation.
Syndicate content